Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P17050: Variant p.Glu325Lys

Alpha-N-acetylgalactosaminidase
Gene: NAGA
Feedback?
Variant information Variant position: help 325 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glutamate (E) to Lysine (K) at position 325 (E325K, p.Glu325Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In SCHIND; type I and type III. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 325 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 411 The length of the canonical sequence.
Location on the sequence: help INQDPLGIQGRRIHKEKSLI E VYMRPLSNKASALVFFSCRT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         INQDPLGIQGRRIHKEKSLIEVYMRPLSNKASALVFFSCRT

Mouse                         INQDPLGIQGRRILKSKSHIEVFKRYLSNQASALVFFSRRT

Rat                           INQDPLGIQGRLIFKSKSHIEVFKRNLSDDASALVFFSRRT

Bovine                        INQDPLGIQGRRILKEKSHIEVYLRPLASEASAIVFFSRRM

Chicken                       INQDPLGIQGRRIIKEGSHIEVFLRPLSQAASALVFFSRRT

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 18 – 411 Alpha-N-acetylgalactosaminidase
Modified residue 322 – 322 Phosphoserine
Modified residue 332 – 332 Phosphoserine
Beta strand 323 – 330



Literature citations
Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy.
Wang A.M.; Schindler D.; Desnick R.J.;
J. Clin. Invest. 86:1752-1756(1990)
Cited for: VARIANT SCHIND LYS-325; Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.
Keulemans J.L.M.; Reuser A.J.J.; Kroos M.A.; Willemsen R.; Hermans M.M.P.; van den Ouweland A.M.W.; de Jong J.G.N.; Wevers R.A.; Renier W.O.; Schindler D.; Coll M.J.; Chabas A.; Sakuraba H.; Suzuki Y.; van Diggelen O.P.;
J. Med. Genet. 33:458-464(1996)
Cited for: VARIANTS SCHIND CYS-160 AND LYS-325;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.